|
|
Volumn 8, Issue 4, 2004, Pages 385-392
|
|
New directions in oncology nursing care: focus on gefitinib in patients with lung cancer.
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANTINEOPLASTIC AGENT;
EPIDERMAL GROWTH FACTOR;
GEFITINIB;
PROTEIN TYROSINE KINASE;
QUINAZOLINE DERIVATIVE;
DOSE RESPONSE;
DRUG ANTAGONISM;
HUMAN;
LUNG NON SMALL CELL CANCER;
LUNG TUMOR;
NURSING;
PATHOPHYSIOLOGY;
PATIENT EDUCATION;
REVIEW;
ANTINEOPLASTIC AGENTS;
CARCINOMA, NON-SMALL-CELL LUNG;
DOSE-RESPONSE RELATIONSHIP, DRUG;
EPIDERMAL GROWTH FACTOR;
HUMANS;
LUNG NEOPLASMS;
PATIENT EDUCATION;
PROTEIN-TYROSINE KINASES;
QUINAZOLINES;
|
|
EID: 4644349963
PISSN: 10921095
EISSN: None
Source Type: Journal
DOI: 10.1188/04.CJON.385-392 Document Type: Review |
|
Times cited : (2)
|
|
References (46)
|
